Avidity of anti-Yersinia antibodies in yersiniosis patients with and without Yersinia-triggered reactive arthritis. 1987

R Lahesmaa-Rantala, and O P Lehtonen, and K Granfors, and A Toivanen
Department of Medical Microbiology, Turku University, Finland.

Avidity of IgM, IgG, and IgA class anti-Yersinia antibodies was compared in sera of 22 patients with yersiniosis and subsequent reactive arthritis versus sera of 22 patients without postinfection complications. An enzyme-linked immunosorbent assay was used for antibody determination. Less than 2 months after onset of the infection, the patients with arthritis had fewer high-avidity IgM antibodies against the bacterial lipopolysaccharide (P = 0.035) and more high-avidity IgA antibodies against bacterial cell extract (P = 0.039) than did the patients without arthritis. This difference increased with time.

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies
D000915 Antibody Affinity A measure of the binding strength between antibody and a simple hapten or antigen determinant. It depends on the closeness of stereochemical fit between antibody combining sites and antigen determinants, on the size of the area of contact between them, and on the distribution of charged and hydrophobic groups. It includes the concept of "avidity," which refers to the strength of the antigen-antibody bond after formation of reversible complexes. Affinity, Antibody,Antibody Avidity,Avidity, Antibody,Affinities, Antibody,Antibody Affinities,Antibody Avidities,Avidities, Antibody
D001168 Arthritis Acute or chronic inflammation of JOINTS. Oligoarthritis,Polyarthritis,Arthritides,Oligoarthritides,Polyarthritides

Related Publications

R Lahesmaa-Rantala, and O P Lehtonen, and K Granfors, and A Toivanen
July 1986, Annals of the rheumatic diseases,
R Lahesmaa-Rantala, and O P Lehtonen, and K Granfors, and A Toivanen
January 1988, Clinical and experimental rheumatology,
R Lahesmaa-Rantala, and O P Lehtonen, and K Granfors, and A Toivanen
August 1994, Annals of the rheumatic diseases,
R Lahesmaa-Rantala, and O P Lehtonen, and K Granfors, and A Toivanen
May 1989, Clinical and experimental immunology,
R Lahesmaa-Rantala, and O P Lehtonen, and K Granfors, and A Toivanen
February 1991, Annals of the rheumatic diseases,
R Lahesmaa-Rantala, and O P Lehtonen, and K Granfors, and A Toivanen
June 1989, The Journal of infectious diseases,
R Lahesmaa-Rantala, and O P Lehtonen, and K Granfors, and A Toivanen
February 1987, Annals of the rheumatic diseases,
R Lahesmaa-Rantala, and O P Lehtonen, and K Granfors, and A Toivanen
July 1992, Journal of internal medicine,
R Lahesmaa-Rantala, and O P Lehtonen, and K Granfors, and A Toivanen
January 1988, Scandinavian journal of rheumatology. Supplement,
R Lahesmaa-Rantala, and O P Lehtonen, and K Granfors, and A Toivanen
July 1987, Annals of the rheumatic diseases,
Copied contents to your clipboard!